Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older

CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421

Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research